Equities

Scancell Holdings PLC

SCLP:LSE

Scancell Holdings PLC

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)13.00
  • Today's Change0.00 / 0.00%
  • Shares traded505.59k
  • 1 Year change44.44%
  • Beta1.2639
Data delayed at least 20 minutes, as of Feb 06 2026 16:13 GMT.
More ▼

Financials data is unavailable for this security.

Cash flow in GBPView more

In 2025, Scancell Holdings PLC increased its cash reserves by 14.02%, or 2.08m. Cash Flow from Financing totalled 9.69m or 205.69% of revenues. In addition the company used 6.40m for operations while cash used for investing totalled 1.20m.
Cash flow per share-0.0047
Price/Cash flow per share--
Book value per share-0.0081
Tangible book value per share-0.0096
More ▼

Balance sheet in GBPView more

Scancell Holdings PLC has a Debt to Total Capital ratio of 207.20%.
Current ratio0.5587
Quick ratio--
Total debt/total equity--
Total debt/total capital2.07
More ▼
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.